Search research articles
Contact Us
Filters
Showing results (1-10 of 157) with videos related to
Page
of 16
Sort By:
The New England Journal of Medicine
|
February 27, 2004
Early malignant progression of hereditary medullary thyroid cancer
Andreas Machens
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Parenchymal versus nonparenchymal target lesion response in clinical trials for metastatic medullary thyroid cancer
Andreas Machens, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism
|
October 7, 2015
Response to the Letter by Linane H.E. and Egan A.O
Andreas Machens, Henning Dralle
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
October 24, 2015
Surgical Treatment of Medullary Thyroid Cancer
Andreas Machens, Henning Dralle
Clinical Endocrinology
|
November 18, 2015
Variability in penetrance of multiple endocrine neoplasia 2A with amino acid substitutions in RET codon 634
Andreas Machens, Henning Dralle
Surgery
|
August 31, 2011
Single nucleotide polymorphisms and development of hereditary medullary thyroid cancer in V804M RET families: disease modification or linkage disequilibrium?
Andreas Machens, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism
|
March 9, 2012
Biological relevance of medullary thyroid microcarcinoma
Andreas Machens, Henning Dralle
Surgery
|
November 3, 2009
Outcome after thyroid surgery for metastasis from renal cell cancer
Andreas Machens, Henning Dralle
European Journal of Endocrinology
|
June 24, 2016
Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening
Andreas Machens, Henning Dralle
Surgery
|
April 26, 2008
Pheochromocytoma penetrance varies by RET mutation in MEN 2A
Andreas Machens, Henning Dralle
Page
of 16
Search research articles
Search
Showing results (1-10 of 157) with videos related to
Sort By:
Page
of 16
The New England Journal of Medicine
|
February 27, 2004
Early malignant progression of hereditary medullary thyroid cancer
Andreas Machens
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2010
Parenchymal versus nonparenchymal target lesion response in clinical trials for metastatic medullary thyroid cancer
Andreas Machens, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism
|
October 7, 2015
Response to the Letter by Linane H.E. and Egan A.O
Andreas Machens, Henning Dralle
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
October 24, 2015
Surgical Treatment of Medullary Thyroid Cancer
Andreas Machens, Henning Dralle
Clinical Endocrinology
|
November 18, 2015
Variability in penetrance of multiple endocrine neoplasia 2A with amino acid substitutions in RET codon 634
Andreas Machens, Henning Dralle
Surgery
|
August 31, 2011
Single nucleotide polymorphisms and development of hereditary medullary thyroid cancer in V804M RET families: disease modification or linkage disequilibrium?
Andreas Machens, Henning Dralle
The Journal of Clinical Endocrinology and Metabolism
|
March 9, 2012
Biological relevance of medullary thyroid microcarcinoma
Andreas Machens, Henning Dralle
Surgery
|
November 3, 2009
Outcome after thyroid surgery for metastasis from renal cell cancer
Andreas Machens, Henning Dralle
European Journal of Endocrinology
|
June 24, 2016
Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening
Andreas Machens, Henning Dralle
Surgery
|
April 26, 2008
Pheochromocytoma penetrance varies by RET mutation in MEN 2A
Andreas Machens, Henning Dralle
Page
of 16